BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 8612531)

  • 1. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats.
    Fielder PJ; Mortensen DL; Mallet P; Carlsson B; Baxter RC; Clark RG
    Endocrinology; 1996 May; 137(5):1913-20. PubMed ID: 8612531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
    Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D
    Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats.
    López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
    Growth Horm IGF Res; 2012 Feb; 22(1):22-9. PubMed ID: 22244673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I.
    Clark RG; Mortensen DL; Carlsson LM; Carlsson B; Carmignac D; Robinson IC
    Endocrinology; 1996 May; 137(5):1904-12. PubMed ID: 8612530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
    Gargosky SE; Tapanainen P; Rosenfeld RG
    Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia.
    Kovács GT; Oh J; Kovács J; Tönshoff B; Hunziker EB; Zapf J; Mehls O
    Kidney Int; 1996 May; 49(5):1413-21. PubMed ID: 8731108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone.
    Gosteli-Peter MA; Winterhalter KH; Schmid C; Froesch ER; Zapf J
    Endocrinology; 1994 Dec; 135(6):2558-67. PubMed ID: 7527334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
    Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
    J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.
    Thrailkill K; Quattrin T; Baker L; Litton J; Dwigun K; Rearson M; Poppenheimer M; Kotlovker D; Giltinan D; Gesundheit N; Martha P
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1181-7. PubMed ID: 9100593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
    Glasscock GF; Hein AN; Miller JA; Hintz RL; Rosenfeld RG
    Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats.
    Domené H; Krishnamurthi K; Eshet R; Gilad I; Laron Z; Koch I; Stannard B; Cassorla F; Roberts CT; LeRoith D
    Endocrinology; 1993 Aug; 133(2):675-82. PubMed ID: 7688291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
    Böni-Schnetzler M; Hauri C; Zapf J
    Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
    Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM
    JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term administration of a combination of recombinant growth hormone and insulin-like growth factor-I induces anabolism in maintenance hemodialysis.
    Guebre-Egziabher F; Juillard L; Boirie Y; Laville M; Beaufrère B; Fouque D
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2299-305. PubMed ID: 19401377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with GH and IGF-I: additive effect on cortical bone mass but not on linear bone growth in female rats.
    Sundström K; Cedervall T; Ohlsson C; Camacho-Hübner C; Sävendahl L
    Endocrinology; 2014 Dec; 155(12):4798-807. PubMed ID: 25243853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.
    Guha N; Erotokritou-Mulligan I; Nevitt SP; Francis M; Bartlett C; Cowan DA; Bassett EE; Sönksen PH; Holt RI
    Drug Test Anal; 2013; 5(11-12):843-9. PubMed ID: 24173773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats.
    Zapf J; Hauri C; Waldvogel M; Futo E; Häsler H; Binz K; Guler HP; Schmid C; Froesch ER
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3813-7. PubMed ID: 2471192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.
    Mauras N
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2633-7. PubMed ID: 7673406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.